×
About 1,025 results

ALLMedicine Parathyroid Carcinoma Center

Research & Reviews  475 results

Synchronous symptomatic parathyroid carcinoma and parathyroid adenoma with incidental f...
https://doi.org/10.1308/rcsann.2020.0101
Annals of the Royal College of Surgeons of England; D'cruz RT, Seet JE et. al.

May 20th, 2020 - We describe the case of an 89-year old Caucasian woman admitted with confusion and severe clinical manifestations of acute hypercalcaemia. There was no history suggestive of any malignancy and initial management included correction of the hypercal...

Multiple concurrent atypical parathyroid adenomas: a rare occurrence.
https://doi.org/10.1136/bcr-2020-234421
BMJ Case Reports; Faulkner J, Varadharajan K et. al.

May 19th, 2020 - We present a case of an 80-year-old patient with three concurrent multiple atypical parathyroid adenomas. The patient was managed with bilateral parathyroid exploration and concurrent parathyroidectomy. Postoperative recovery was uneventful. Atypi...

New and future perspectives for parathyroid carcinoma.
https://doi.org/10.1530/ERC-20-0018
Endocrine-related Cancer; Perrier ND, Arnold A et. al.

Apr 30th, 2020 - This report summarizes published data on parathyroid cancer, with the inclusion of topics discussed at the 16th International Workshop on Multiple Endocrine Neoplasia (MEN2019), 27-29 March 2019, Houston, TX, USA. An expert panel on parathyroid ca...

Pitfalls of using denosumab preoperatively to treat refractory severe hypercalcaemia.
https://doi.org/10.1136/bcr-2019-233665
BMJ Case Reports; Li Y, Fan CY et. al.

Apr 27th, 2020 - A 40-year-old man, with a history of metastatic parathyroid carcinoma, status post primary tumour resection and lung metastasectomy, was hospitalised for persistent severe hypercalcaemia and elevated parathyroid hormone levels despite conventional...

Evocalcet in patients with primary hyperparathyroidism: an open-label, single-arm, mult...
https://doi.org/10.1007/s00774-020-01097-y
Journal of Bone and Mineral Metabolism; Takeuchi Y, Nishida Y et. al.

Apr 8th, 2020 - Primary hyperparathyroidism (PHPT) is caused by parathyroid adenoma, primary parathyroid hyperplasia, or parathyroid carcinoma. For some patients with PHPT controlling serum calcium levels is critical. We conducted an open-label, single-arm, 52-we...

see more →

Guidelines  1 results

2009 EANM parathyroid guidelines.
https://doi.org/10.1007/s00259-009-1131-z
European Journal of Nuclear Medicine and Molecular Imaging; Hindié E, Ugur O et. al.

May 27th, 2009 - The present guidelines were issued by the Parathyroid Task Group of the European Association of Nuclear Medicine. The main focus was imaging of primary hyperparathyroidism. Dual-tracer and single-tracer parathyroid scintigraphy protocols were disc...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  515 results

Synchronous symptomatic parathyroid carcinoma and parathyroid adenoma with incidental f...
https://doi.org/10.1308/rcsann.2020.0101
Annals of the Royal College of Surgeons of England; D'cruz RT, Seet JE et. al.

May 20th, 2020 - We describe the case of an 89-year old Caucasian woman admitted with confusion and severe clinical manifestations of acute hypercalcaemia. There was no history suggestive of any malignancy and initial management included correction of the hypercal...

Multiple concurrent atypical parathyroid adenomas: a rare occurrence.
https://doi.org/10.1136/bcr-2020-234421
BMJ Case Reports; Faulkner J, Varadharajan K et. al.

May 19th, 2020 - We present a case of an 80-year-old patient with three concurrent multiple atypical parathyroid adenomas. The patient was managed with bilateral parathyroid exploration and concurrent parathyroidectomy. Postoperative recovery was uneventful. Atypi...

Cinacalcet - cinacalcet tablet-Cipla USA Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02b8c11b-99e8-4039-b6fa-a9c38d2f48fa

May 18th, 2020 - Cinacalcet hydrochloride is a calcium-sensing receptor agonist indicated for: Secondary Hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. (1.1) Limitations of Use: Cinacalcet hydrochloride tablets are not i...

New and future perspectives for parathyroid carcinoma.
https://doi.org/10.1530/ERC-20-0018
Endocrine-related Cancer; Perrier ND, Arnold A et. al.

Apr 30th, 2020 - This report summarizes published data on parathyroid cancer, with the inclusion of topics discussed at the 16th International Workshop on Multiple Endocrine Neoplasia (MEN2019), 27-29 March 2019, Houston, TX, USA. An expert panel on parathyroid ca...

Pitfalls of using denosumab preoperatively to treat refractory severe hypercalcaemia.
https://doi.org/10.1136/bcr-2019-233665
BMJ Case Reports; Li Y, Fan CY et. al.

Apr 27th, 2020 - A 40-year-old man, with a history of metastatic parathyroid carcinoma, status post primary tumour resection and lung metastasectomy, was hospitalised for persistent severe hypercalcaemia and elevated parathyroid hormone levels despite conventional...

see more →

News  3 results

Cinacalcet Reduces Hypercalcemia in Patients with Parathyroid Cancer
https://www.medscape.com/viewarticle/563087

Sep 19th, 2007 - September 19, 2007--Cinacalcet ( Sensipar, Amgen) may emerge as an important new therapeutic option for patients with inoperable parathyroid carcinoma, researchers report. According to the results of a study published in the October issue of the J...

PTH Immunization Shrinks Tumors in Patient With Metastatic Parathyroid Carcinoma
https://www.medscape.com/viewarticle/484152

Jul 22nd, 2004 - July 23, 2004 -- Parathyroid hormone (PTH) immunization results in tumor regression and normalization of clinical, hormonal, and biochemical parameters in patients with metastatic parathyroid carcinoma, according to a case study presented in the J...

see more →